MARCHF5 and hypertrophy: MARCH5 heterozygous (MARCH5+/−) mice subjected to transverse aortic constriction (TAC) demonstrated alleviation of cardiac hypertrophy and improvement in cardiac function, whereas MARCH5 overexpression aggravated hypertrophy and cardiac dysfunction.